The House Judiciary Committee, led by Chair Jim Jordan (R-Ohio), opened an investigation into possible anticompetitive practices by the company’s PBM, CVS Caremark, in December 2024, seeking to examine the company’s relationship with pharmaceutical hubs, third-party online services designed to streamline patient access to complex specialty medication and increase price transparency.